Literature DB >> 17398105

Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism.

Saravanan S Karuppagounder1, Qingli Shi, Hui Xu, Gary E Gibson.   

Abstract

Abnormalities in oxidative metabolism and reductions of thiamine-dependent enzymes accompany many age-related neurodegenerative diseases. Thiamine deficiency (TD) produces a cascade of events including mild impairment of oxidative metabolism, activation of microglia, astrocytes and endothelial cells that leads to neuronal loss in select brain regions. The earliest changes occur in a small, well-defined brain region, the submedial thalamic nucleus (SmTN). In the present study, a micropunch technique was used to evaluate quantitatively the selective regional changes in mRNA and protein levels. To test whether this method can distinguish between changes in vulnerable and non-vulnerable regions, markers for neuronal loss (NeuN) and endothelial cells (eNOS) and inflammation (IL-1beta, IL-6 and TNF-alpha) in SmTN and cortex of control and TD mice were assessed. TD significantly reduced NeuN and increased CD11b, GFAP and ICAM-1 immunoreactivity in SmTN as revealed by immunocytochemistry. When assessed on samples obtained by the micropunch method, NeuN protein declined (-49%), while increased mRNA levels were observed for eNOS (3.7-fold), IL-1beta (43-fold), IL-6 (44-fold) and TNF-alpha (64-fold) in SmTN with TD. The only TD-induced change that occurred in cortex with TD was an increase in TNF-alpha (22-fold) mRNA levels. Immunocytochemical analysis revealed that IL-1beta, IL-6 and TNF-alpha protein levels increased in TD brains and colocalized with glial markers. The consistency of these quantitative results with immunocytochemical measurements validates the micropunch technique. The results demonstrate that TD induces quantitative, distinct inflammatory responses and oxidative stress in vulnerable and non-vulnerable regions that may underlie selective vulnerability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17398105      PMCID: PMC2753424          DOI: 10.1016/j.nbd.2007.01.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  46 in total

Review 1.  MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies.

Authors:  E Grünblatt; S Mandel; M B Youdim
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

2.  Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment.

Authors:  D S Albers; S J Augood; L C Park; S E Browne; D M Martin; J Adamson; M Hutton; D G Standaert; J P Vonsattel; G E Gibson; M F Beal
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

3.  Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism.

Authors:  N Y Calingasan; P L Huang; H S Chun; A Fabian; G E Gibson
Journal:  J Neuropathol Exp Neurol       Date:  2000-03       Impact factor: 3.685

4.  Dietary restriction attenuates the neuronal loss, induction of heme oxygenase-1 and blood-brain barrier breakdown induced by impaired oxidative metabolism.

Authors:  N Y Calingasan; G E Gibson
Journal:  Brain Res       Date:  2000-12-01       Impact factor: 3.252

Review 5.  Interleukin-6 expression and regulation in astrocytes.

Authors:  N J Van Wagoner; E N Benveniste
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

6.  Increased brain endothelial nitric oxide synthase expression in thiamine deficiency: relationship to selective vulnerability.

Authors:  Milarca Kruse; Darren Navarro; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2004-07       Impact factor: 3.921

7.  Reversal of thiamine deficiency-induced neurodegeneration.

Authors:  Zun-Ji Ke; Lorraine A DeGiorgio; Bruce T Volpe; Gary E Gibson
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

Review 8.  Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism.

Authors:  Zun-Ji Ke; Gary E Gibson
Journal:  Neurochem Int       Date:  2004 Jul-Aug       Impact factor: 3.921

9.  Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity.

Authors:  Peter Klivenyi; Anatoly A Starkov; Noel Y Calingasan; Gabrielle Gardian; Susan E Browne; Lichuan Yang; Parvesh Bubber; Gary E Gibson; Mulchand S Patel; M Flint Beal
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

10.  Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus.

Authors:  Jean-Marc Collombet; Catherine Masqueliez; Elise Four; Marie-France Burckhart; Denis Bernabé; Dominique Baubichon; Guy Lallement
Journal:  Neurosci Lett       Date:  2006-02-09       Impact factor: 3.046

View more
  27 in total

1.  Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.

Authors:  Silke Heinisch; Jonathan Palma; Lynn G Kirby
Journal:  Brain Behav Immun       Date:  2010-10-23       Impact factor: 7.217

Review 2.  Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease.

Authors:  Gary E Gibson; Saravanan S Karuppagounder; Qingli Shi
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

3.  Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

Authors:  Saravanan S Karuppagounder; John T Pinto; Hui Xu; Huan-Lian Chen; M Flint Beal; Gary E Gibson
Journal:  Neurochem Int       Date:  2008-11-08       Impact factor: 3.921

Review 4.  Metabolic and structural role of thiamine in nervous tissues.

Authors:  Abdoulaye Bâ
Journal:  Cell Mol Neurobiol       Date:  2008-07-19       Impact factor: 5.046

5.  Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.

Authors:  Saravanan S Karuppagounder; Hui Xu; Qingli Shi; Lian H Chen; Steve Pedrini; David Pechman; Harriet Baker; M Flint Beal; Sam E Gandy; Gary E Gibson
Journal:  Neurobiol Aging       Date:  2008-04-10       Impact factor: 4.673

6.  Loss of astrocytic glutamate transporters in Wernicke encephalopathy.

Authors:  Alan S Hazell; Donna Sheedy; Raluca Oanea; Meghmik Aghourian; Simon Sun; Jee Yong Jung; Dongmei Wang; Chunlei Wang
Journal:  Glia       Date:  2010-01-15       Impact factor: 7.452

Review 7.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

8.  A Pivotal Role for Thiamine Deficiency in the Expression of Neuroinflammation Markers in Models of Alcohol-Related Brain Damage.

Authors:  Polliana Toledo Nunes; Lindsey C Vedder; Terrence Deak; Lisa M Savage
Journal:  Alcohol Clin Exp Res       Date:  2019-01-20       Impact factor: 3.455

9.  Autophagy alleviates neurodegeneration caused by mild impairment of oxidative metabolism.

Authors:  Ya Meng; Yue Yong; Guang Yang; Hanqing Ding; Zhiqin Fan; Yifen Tang; Jia Luo; Zun-Ji Ke
Journal:  J Neurochem       Date:  2013-06-09       Impact factor: 5.372

10.  Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability.

Authors:  Q Shi; S S Karuppagounder; H Xu; D Pechman; H Chen; G E Gibson
Journal:  Neurochem Int       Date:  2007-04-07       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.